Frank Beier renewed as Canada Research Chair in Musculoskeletal Research

Schulich Medicine & Dentistry professor Frank Beier, PhD, has been renewed as the Canada Research Chair in Musculoskeletal Research (Tier 1).

The renewal comes as part of a new round of investments in CRCs announced this week by the Government of Canada, totaling more than $151 million.

Beier is Chair of the Department of Physiology and Pharmacology at Schulich Medicine & Dentistry, and a member of Western University’s Bone and Joint Institute. His research lab focuses on skeletal physiology, cartilage biology, bone development and osteoarthritis.

An established international leader in research on mechanisms driving progression of osteoarthritis (OA), Beier is now aiming to build on earlier studies with three research themes: studying the role of selected pathways in different types of OA in various joint tissues; exploring the links between OA and comorbidities such as Alzheimer’s and metabolic diseases; and optimizing therapeutic approaches for OA treatment.

The CRC program is designed to attract and retain some of the world’s most accomplished and promising minds in engineering, natural sciences, health sciences, humanities and social sciences.

The CRC program is supported by participating universities and funded through three federal funding agencies: Social Sciences and Humanities Research Council (SSHRC), the Natural Sciences and Engineering Research Council (NSERC), and the Canadian Institutes of Health Research (CIHR). There are two levels to the CRC program: Tier 1 chairs (seven-year term) are recognized by their peers as world leaders in their respective fields, while Tier 2 chairs (five-year term) are recognized as emerging leaders in their research areas.